20S proteasome and its inhibitors: Crystallographic knowledge for drug development

Ljudmila Borissenko, Michael Groll

Publikation: Beitrag in FachzeitschriftÜbersichtsartikelBegutachtung

383 Zitate (Scopus)

Abstract

An overview of the latest insights on the structure and function of the proteasome is given highlighting the structural features that determine its activity and specificity. Focus is on the current structural knowledge of the mechanisms of regulation and modulation of proteasomal activity by various natural and synthetic chemical compounds, showing the proteasome as a potential target for drug development in biomedical research. The mechanisms in action of various proteasomal inhibitors and spans scientific publications from 1997 to 2006 are described in detail.

OriginalspracheEnglisch
Seiten (von - bis)687-717
Seitenumfang31
FachzeitschriftChemical Reviews
Jahrgang107
Ausgabenummer3
DOIs
PublikationsstatusVeröffentlicht - März 2007
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „20S proteasome and its inhibitors: Crystallographic knowledge for drug development“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren